Cingolani, Antonella
 Distribuzione geografica
Continente #
NA - Nord America 5.843
AS - Asia 3.353
EU - Europa 3.322
SA - Sud America 775
Continente sconosciuto - Info sul continente non disponibili 190
AF - Africa 144
OC - Oceania 27
Totale 13.654
Nazione #
US - Stati Uniti d'America 5.601
SG - Singapore 1.476
IT - Italia 850
CN - Cina 692
BR - Brasile 628
DE - Germania 611
SE - Svezia 502
FR - Francia 339
VN - Vietnam 329
GB - Regno Unito 210
IE - Irlanda 142
UA - Ucraina 140
CA - Canada 128
FI - Finlandia 123
IN - India 118
ID - Indonesia 96
JP - Giappone 96
HK - Hong Kong 95
PL - Polonia 87
BD - Bangladesh 80
RU - Federazione Russa 72
NL - Olanda 64
MX - Messico 57
TR - Turchia 55
AR - Argentina 50
PK - Pakistan 39
AT - Austria 36
IQ - Iraq 36
BE - Belgio 33
SA - Arabia Saudita 32
PH - Filippine 28
ZA - Sudafrica 28
KR - Corea 27
IR - Iran 26
AU - Australia 25
VE - Venezuela 24
ES - Italia 22
MY - Malesia 21
EC - Ecuador 20
EG - Egitto 19
CO - Colombia 18
MA - Marocco 18
TN - Tunisia 18
KE - Kenya 16
CH - Svizzera 13
CL - Cile 13
LT - Lituania 13
AE - Emirati Arabi Uniti 12
JO - Giordania 12
UZ - Uzbekistan 12
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 9
IL - Israele 9
NG - Nigeria 9
NP - Nepal 9
TT - Trinidad e Tobago 9
CR - Costa Rica 8
PT - Portogallo 8
JM - Giamaica 7
KG - Kirghizistan 7
PE - Perù 7
PY - Paraguay 7
RO - Romania 7
AZ - Azerbaigian 6
TH - Thailandia 6
TW - Taiwan 6
BG - Bulgaria 5
EE - Estonia 5
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
LV - Lettonia 5
NI - Nicaragua 5
UY - Uruguay 5
ET - Etiopia 4
EU - Europa 4
MM - Myanmar 4
NO - Norvegia 4
PR - Porto Rico 4
AO - Angola 3
BB - Barbados 3
BZ - Belize 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
KW - Kuwait 3
LB - Libano 3
OM - Oman 3
SD - Sudan 3
SK - Slovacchia (Repubblica Slovacca) 3
BW - Botswana 2
BY - Bielorussia 2
CM - Camerun 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MG - Madagascar 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
Totale 13.440
Città #
Singapore 778
Ashburn 546
San Jose 525
Chandler 487
Rome 215
New York 189
Dublin 139
Beijing 124
Dallas 123
Ho Chi Minh City 122
Los Angeles 105
Milan 105
Jacksonville 92
Tokyo 90
Lauterbourg 87
The Dalles 85
Jakarta 82
Chicago 81
San Mateo 80
Hanoi 78
Hefei 76
Hong Kong 75
Nanjing 67
Ann Arbor 61
São Paulo 59
Wilmington 59
Helsinki 54
Boston 53
Council Bluffs 53
Munich 52
Redmond 51
Frankfurt am Main 50
Dearborn 46
Princeton 46
St Louis 46
Boardman 45
Kraków 45
Atlanta 43
Moscow 40
London 38
Orem 37
Santa Clara 36
Houston 35
Marseille 35
Bremen 34
North Bergen 34
Nuremberg 31
Amsterdam 30
Montreal 30
Brussels 29
Buffalo 29
Cattolica 28
Kent 26
Woodbridge 26
Warsaw 25
Nürnberg 24
Phoenix 24
Nanchang 23
Rio de Janeiro 23
Brooklyn 22
Izmir 22
Ottawa 22
Da Nang 21
Paris 21
San Francisco 21
Seoul 21
Guangzhou 20
Redwood City 20
Seattle 20
Lappeenranta 19
Turku 19
Fairfield 18
Lawrence 18
Haiphong 17
Johannesburg 17
Vienna 17
Denver 16
Düsseldorf 16
Lancaster 16
Pune 16
Stockholm 16
Baghdad 15
Kunming 15
Mexico City 15
Toronto 15
Las Vegas 14
Norwalk 14
Poplar 14
Tianjin 14
Augusta 13
Chennai 13
Dammam 13
Dhaka 13
Lahore 13
Amman 12
Fremont 12
Nairobi 12
Washington 12
Abidjan 11
Belo Horizonte 11
Totale 6.417
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 535
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 417
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 349
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 346
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 328
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy. 297
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 271
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients 261
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 245
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 245
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 238
Long-acting agents for HIV infection: biological aspects, role in treatment and prevention, and patient's perspective 225
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 218
COVID-19 atypical Parsonage-Turner syndrome: a case report 212
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: Data from the ICONA foundation study group, years 1997-2013 211
Malnutrition in COVID-19 survivors: prevalence and risk factors 207
Residual respiratory impairment after COVID-19 pneumonia 202
Plasma levels of Interleukin-6 and Interleukin-10 in preterm neonates evaluated for sepsis 202
Residual respiratory impairment after COVID-19 pneumonia 187
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 185
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 181
Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. 178
Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma 173
Sarilumab use in severe SARS-CoV-2 pneumonia 171
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 170
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis 165
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure 164
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 161
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 159
Asymmetry of the regimen is correlated to self-reported suboptimal adherence: results from AdUCSC, a cohort study on adherence in Italy 157
Cauda Equina Enhancing Lesion in an HIV-Infected Patient. Case Report and Literature Review. 150
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital 149
Genotypic resistance profile and clinical progression of treatment-experienced HIV type 1-infected patients with virological failure. 148
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media 145
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 143
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 142
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 141
Simultaneous onset of mycobacterium kansasii pulmonary infection and systemic lupus erythematosus: A case report 140
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 136
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 135
“Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial” 135
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 133
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 132
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19 130
Social media as a tool for scientific updating at the time of COVID pandemic: Results from a national survey in Italy 128
Interpretation systems for genotypic drug resistance of HIV-1 126
Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study) 126
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 126
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 123
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study 120
First description of the katG gene deletion in a Mycobacterium tuberculosis clinical isolate and its impact on the mycobacterial fitness 120
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 119
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? 118
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 116
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 116
Prolonged survival in HIV-associated Progressive Multifocal Leukoencephalopathy treated with Pembrolizumab: a case series on treatment and long-term follow-up 115
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry 114
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy 114
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients 114
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022 113
Clinical implications of HIV-1 drug resistance in the neurological compartment 113
Cerebrospinal fluid drain infection caused by pandrug-resistant Staphylococcus epidermidis successfully treated with ceftaroline in combination with fosfomycin and vancomycin 111
Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART 109
Outbreaks of autochthonous Dengue in Lazio region, Italy, August to September 2023: preliminary investigation 107
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure. 104
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 104
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 104
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 103
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
[Treating HIV disease: back to the patient?] 100
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition 99
Impact of SARS-CoV-2 vaccination and passive prophylaxis with tixagevimab/cilgavimab on CAR-T patients: a three-year regional experience from the Italian covid pandemic 98
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 97
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials 95
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 92
Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting 89
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 84
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 83
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial 79
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 78
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 77
Effect of Lockdowns on Hospital Staff in a COVID Center: A Retrospective Observational Study 73
Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort 73
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 72
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 71
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study 62
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis 60
Is the rate of virological failure to cART continuing to decline in recent calendar years? 56
Treatment outcomes and relapses of pulmonary tuberculosis in Lazio, Italy, 1999-2001: a six-year follow-up study 52
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments 51
Prognostic Value of Procalcitonin in Febrile People Living with Human Immunodeficiency Virus (PLWH) Admitted to the Emergency Department 40
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 34
Lopinavir/ritonavir and darunavir/cobicistat in hospitalized covid-19 patients: Findings from the multicenter italian corist study 16
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 9
Real-World Application of Recommended Practices in Nocardiosis 8
Acute promyelocytic leukemia in an HIV-infected patient: a case report 6
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients 5
PROs Assessment in Dual (Either Oral or Injectable) Antiretroviral Regimen in People with HIV: A Narrative Review 5
Acute promyelocytic leukemia in an HIV-infected patient: A case report [3] 4
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 3
Totale 13.654
Categoria #
all - tutte 56.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022572 0 0 14 41 32 20 12 99 33 54 110 157
2022/20231.824 190 187 182 335 175 233 86 97 185 70 63 21
2023/2024929 42 198 37 52 40 167 67 36 22 61 83 124
2024/20252.080 36 52 126 102 144 95 138 92 321 192 401 381
2025/20265.034 660 205 388 597 766 274 748 252 394 409 157 184
2026/20271.517 217 1.186 114 0 0 0 0 0 0 0 0 0
Totale 13.654